AI Terminal
CRANEWARE PLC
Notice of Dividend Amount • Mar 19, 2021
7581_rns_2021-03-19_89f4f96a-59db-4f68-b1ef-f64f70b41942.html
Notice of Dividend Amount
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 9042S
Craneware plc
19 March 2021
19 March 2021
Craneware plc
("Craneware" or the "Company")
Dividend Currency Election
19 March 2021 - Craneware plc (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, today gives further information regarding its final dividend announced on 1 March 2021.
For those shareholders who have previously registered to receive their dividend in US dollars under the Company's Dividend Currency Election, the dividend will be paid at an exchange rate of $1.39.
For further information, please contact:
| Craneware plc | +44 (0)131 550 3100 |
| Keith Neilson, CEO | |
| Craig Preston, CFO | |
| Alma (Financial PR) | +44 (0)20 3405 0212 |
| Caroline Forde, Robyn Fisher, Helena Bogle, Joe Pederzolli | [email protected] |
| Peel Hunt (NOMAD and Joint Broker) | +44 (0)20 7418 8900 |
| Dan Webster, George Sellar, Andrew Clark | |
| Investec Bank PLC (Joint Broker) | +44 (0)20 7597 5970 |
| Patrick Robb, Henry Reast, Sebastian Lawrence | |
| Berenberg (Joint Broker) | +44 (0)20 3207 7800 |
| Mark Whitmore, James White, Alix Mecklenburg-Solodkoff |
About Craneware
Craneware (AIM: CRW.L), develops and provides financial and operational optimisation software & analytics. Craneware is the leader in automated value cycle solutions, collaborates with U.S. healthcare providers to plan, execute and monitor value-based economic performance. Our passion and purpose is to impact healthcare profoundly by improving healthcare providers' operational efficiency and margin, so they can continue investing in providing quality care for their communities.
Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware's value cycle management suite includes charge capture, strategic pricing, patient engagement, claims analytics, revenue recovery and retention, and cost and margin intelligence solutions.
Learn more at www.craneware.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DIVEADDNFELFEFA